Persistence of the immune response after two doses of ChAdOx1 nCov-19 (AZD1222): 1 year of follow-up of two randomized controlled trials

The trajectory of immune responses following the primary dose series determines the decline in vaccine effectiveness over time. Here we report on maintenance of immune responses during the year following a two-dose schedule of ChAdOx1 nCoV-19/AZD1222, in the absence of infection, and also explore th...

Descripción completa

Detalles Bibliográficos
Autores principales: Voysey, Merryn, Flaxman, Amy, Aboagye, Jeremy, Aley, Parvinder K, Belij-Rammerstorfer, Sandra, Bibi, Sagida, Bittaye, Mustapha, Cappuccini, Federica, Charlton, Sue, Clutterbuck, Elizabeth A, Davies, Sophie, Dold, Christina, Edwards, Nick J, Ewer, Katie J, Faust, Saul N, Folegatti, Pedro M, Fowler, Jamie, Gilbride, Ciaran, Gilbert, Sarah C, Godfrey, Leila, Hallis, Bassam, Humphries, Holly E, Jenkin, Daniel, Kerridge, Simon, Mujadidi, Yama F, Plested, Emma, Ramasamy, Maheshi N, Robinson, Hannah, Sanders, Helen, Snape, Matthew D, Song, Rinn, Thomas, Kelly M, Ulaszewska, Marta, Woods, Danielle, Wright, Daniel, Pollard, Andrew J, Lambe, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Vaccine Development
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10038323/
https://www.ncbi.nlm.nih.gov/pubmed/36729167
http://dx.doi.org/10.1093/cei/uxad013

Ejemplares similares

Ejemplares similares